A multicentre study evaluating the presence of glycosil phosphatidyl-inositol (GPI)-negative populations was performed in 85 children with acquired aplastic anemia (AA). A GPI-negative population was observed in 41% of patients at diagnosis, 48% during immune-suppressive therapy (IST), and 45% in patients off-therapy. No association was found between the presence of a GPI-negative population at diagnosis and the response to IST. In addition, the response rate to IST did not differ between the patients who were GPI-positive at diagnosis and later developed GPI-negative populations and the 11 patients who remained GPI-positive. Two patients with a GPI-negative population >10%, and laboratory signs of hemolysis without hemoglobinuria were considered affected by paroxysmal nocturnal hemoglobinuria (PNH) secondary to AA; no thrombotic event was reported. Excluding the 2 patients with a GPI-negative population greater than 10%, we did not observe a significant correlation between LDH levels and GPI-negative population size. In this study monitoring for laboratory signs of hemolysis was sufficient to diagnose PNH in AA patients. The presence of minor GPI-negative populations at diagnosis in our series did not influence the therapeutic response. As occasionally the appearance of a GPI-negative population was observed at cyclosporine (CSA) tapering or AA relapse, a possible role of GPI-negative population monitoring during IST modulation may need further investigation.

Timeus, F., Crescenzio, N., Longoni, D., Doria, A., Foglia, L., Pagliano, S., et al. (2014). Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anemia: A multicentre study. PLOS ONE, 9(7), e101948 [10.1371/journal.pone.0101948].

Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anemia: A multicentre study

PALUMBO, GIUSEPPE;
2014

Abstract

A multicentre study evaluating the presence of glycosil phosphatidyl-inositol (GPI)-negative populations was performed in 85 children with acquired aplastic anemia (AA). A GPI-negative population was observed in 41% of patients at diagnosis, 48% during immune-suppressive therapy (IST), and 45% in patients off-therapy. No association was found between the presence of a GPI-negative population at diagnosis and the response to IST. In addition, the response rate to IST did not differ between the patients who were GPI-positive at diagnosis and later developed GPI-negative populations and the 11 patients who remained GPI-positive. Two patients with a GPI-negative population >10%, and laboratory signs of hemolysis without hemoglobinuria were considered affected by paroxysmal nocturnal hemoglobinuria (PNH) secondary to AA; no thrombotic event was reported. Excluding the 2 patients with a GPI-negative population greater than 10%, we did not observe a significant correlation between LDH levels and GPI-negative population size. In this study monitoring for laboratory signs of hemolysis was sufficient to diagnose PNH in AA patients. The presence of minor GPI-negative populations at diagnosis in our series did not influence the therapeutic response. As occasionally the appearance of a GPI-negative population was observed at cyclosporine (CSA) tapering or AA relapse, a possible role of GPI-negative population monitoring during IST modulation may need further investigation.
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/38 - Pediatria Generale e Specialistica
English
Timeus, F., Crescenzio, N., Longoni, D., Doria, A., Foglia, L., Pagliano, S., et al. (2014). Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anemia: A multicentre study. PLOS ONE, 9(7), e101948 [10.1371/journal.pone.0101948].
Timeus, F; Crescenzio, N; Longoni, D; Doria, A; Foglia, L; Pagliano, S; Vallero, S; Decimi, V; Svahn, J; Palumbo, G; Ruggiero, A; Martire, B; Pillon, M; Marra, N; Dufour, C; Ramenghi, U; Saracco, P
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
PNH Clones in Pediatric Acquired Aplastic Anemia.pdf

accesso aperto

Licenza: Copyright dell'editore
Dimensione 467.5 kB
Formato Adobe PDF
467.5 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/129953
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 36
  • ???jsp.display-item.citation.isi??? ND
social impact